Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes.
Weidner H, Baschant U, Lademann F, Ledesma Colunga MG, Balaian E, Hofbauer C, Misof BM, Roschger P, Blouin S, Richards WG, Platzbecker U, Hofbauer LC, Rauner M.
Weidner H, et al. Among authors: hofbauer c, hofbauer lc.
JCI Insight. 2020 Aug 6;5(15):e137062. doi: 10.1172/jci.insight.137062.
JCI Insight. 2020.
PMID: 32759495
Free PMC article.